Literature DB >> 1371489

Isolation and characterization of a human gene that encodes a new subclass of protein tyrosine kinases.

A Bräuninger1, U Holtrich, K Strebhardt, H Rübsamen-Waigmann.   

Abstract

We describe the isolation and cDNA sequence of a novel human gene, which is distinct from all known members of the human src family of proto-oncogenes. In contrast to these, an autophosphorylation site corresponding to Tyr416, as well as the equivalent of Tyr527 in p60c-src, are missing in the amino acid (aa) sequence deduced from this gene. Furthermore, no N-terminal myristylation site is found. Our human clone is 98% identical at the aa level to a gene which was isolated independently from neonatal rat brain and was termed csk for c-src kinase. We, therefore, propose to designate the present human gene CSK. In Northern blot experiments, CSK was found to be expressed in human lung and macrophages. Due to its extreme conservation across species barriers, the CSK product is likely to exert important regulatory functions. On the basis of its expression in tissues, not typically expressing high c-src levels, it can be assumed that its regulatory role is more general and may also involve other tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371489     DOI: 10.1016/0378-1119(92)90649-a

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Proteins at work: a combined small angle X-RAY scattering and theoretical determination of the multiple structures involved on the protein kinase functional landscape.

Authors:  Michael A Jamros; Leandro C Oliveira; Paul C Whitford; José N Onuchic; Joseph A Adams; Donald K Blumenthal; Patricia A Jennings
Journal:  J Biol Chem       Date:  2010-08-26       Impact factor: 5.157

2.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

3.  Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.

Authors:  Sungsoo Lee; Xiaofeng Lin; Nguyen Hai Nam; Keykavous Parang; Gongqin Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

4.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.

Authors:  U Holtrich; G Wolf; A Bräuninger; T Karn; B Böhme; H Rübsamen-Waigmann; K Strebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

5.  Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination.

Authors:  Pei-Shan Wang; Jing Wang; Zhi-Cheng Xiao; Catherine J Pallen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

6.  Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family.

Authors:  S Klages; D Adam; K Class; J Fargnoli; J B Bolen; R C Penhallow
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

7.  Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85.

Authors:  M Koegl; R M Kypta; M Bergman; K Alitalo; S A Courtneidge
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

8.  Substrate-specific reorganization of the conformational ensemble of CSK implicates novel modes of kinase function.

Authors:  Michael A Jamros; Leandro C Oliveira; Paul C Whitford; José N Onuchic; Joseph A Adams; Patricia A Jennings
Journal:  PLoS Comput Biol       Date:  2012-09-20       Impact factor: 4.475

9.  IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes.

Authors:  T Musso; L Varesio; X Zhang; T K Rowe; P Ferrara; J R Ortaldo; J J O'Shea; D W McVicar
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.